Antimicrobial prescription patterns and ventilator associated pneumonia: findings from a 10-site prospective audit.
Rosalind M ElliottAnthony R BurrellPeter W HarriganMargherita MurgoKaye D RollsDavid W SibbrittJonathan R IredellDoug ElliottPublished in: BMC research notes (2018)
The patient sample of 169 was 65% male with an average age of 59.7 years, a mean APACHE II score of 20.6, and a median ICU stay of 11 days. While ventilator-associated pneumonia was identified using a specific 4-item checklist in 29 patients, agreement between the checklist and independent physician diagnosis was only 17%. Sputum microbe culture reporting was sparse. Approximately 75% of the sample was administered an antimicrobial (main indications: lung infection [54%] and prophylaxis [11%]). No clinical justification was documented for 20% of prescriptions. Piperacillin/tazobactam was most frequently prescribed (1/3rd of all antimicrobial prescriptions) with about half of those for prophylaxis. Variations in prescribing practices were identified, including apparent gaps in antimicrobial stewardship; particularly in relation to prescribing for prophylaxis and therapy de-escalation. Sputum microbe culture reports for VAP did not appear to contribute to prescribing decisions but physician suspicion of lung infection and empiric therapy rather than ventilator-associated pneumonia criteria and guideline concordance.
Keyphrases
- primary care
- adverse drug
- staphylococcus aureus
- end stage renal disease
- cystic fibrosis
- emergency department
- mycobacterium tuberculosis
- newly diagnosed
- ejection fraction
- pulmonary tuberculosis
- chronic kidney disease
- prognostic factors
- case report
- community acquired pneumonia
- peritoneal dialysis
- stem cells
- magnetic resonance imaging
- clinical trial
- patient reported outcomes
- mesenchymal stem cells
- computed tomography
- patient reported
- study protocol
- psychometric properties